Robyn Reynolds1, Bernard Rosner, Johanna M Seddon. 1. Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts 02111, USA.
Abstract
OBJECTIVE: To investigate associations between dietary omega-3 fatty acids and other fat intake, genes related to age-related macular degeneration (AMD), and progression to geographic atrophy (GA). DESIGN: Observational analysis of a prospective cohort. PARTICIPANTS: A total of 2531 individuals from the Age-Related Eye Disease Study, among which 525 eyes progressed to GA and 4165 eyes did not. METHODS: Eyes without advanced AMD at baseline were evaluated for progression to GA. Behavioral data, including smoking and body mass index measurements, were collected at baseline using questionnaires. Dietary data were collected from food frequency questionnaires (FFQs) at baseline. Omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]), omega-6 fatty acids, monounsaturated, saturated, polyunsaturated, and total fat were adjusted for sex and calories and divided into quintiles (Q). Eight single nucleotide polymorphisms in 7 genes (CFH, ARMS2/HTRA1, CFB, C2, C3, CFI, and LIPC) were genotyped. Cox proportional hazards models were used to test for associations between incident GA and intake of dietary lipids and interaction effects between dietary fat intake and genetic variation on risk of GA. MAIN OUTCOME MEASURES: Associations between dietary fat intake reported from FFQs, genetic variants, and incident GA. RESULTS: Increased intake of DHA was significantly associated with reduced risk of progression to GA in models with behavioral factors (model A) plus genetic variants (model B) (P trend = 0.01 and 0.03, respectively). Total omega-3 long chain polyunsaturated (DHA + EPA) fatty acid intake was significantly associated with reduced risk of progression in model B (P trend = 0.02). Monounsaturated fat was associated with increased risk in model A (P trend = 0.05). DHA intake was significantly associated with reduced risk of incident GA among those with the ARMS2/HTRA1 homozygous risk genotype (hazard ratio [HR] Q5 vs Q1, 0.4; P = 0.002; P for interaction between gene and fat intake = 0.05). DHA was not associated with reduced risk of GA among those with the homozygous ARMS2/HTRA1 nonrisk genotype (HR, 1.0; P = 0.90). CONCLUSIONS: Increased self-reported dietary intake of omega-3 fatty acids is associated with reduced risk of GA and may modify genetic susceptibility for progression to GA. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
OBJECTIVE: To investigate associations between dietary omega-3 fatty acids and other fat intake, genes related to age-related macular degeneration (AMD), and progression to geographic atrophy (GA). DESIGN: Observational analysis of a prospective cohort. PARTICIPANTS: A total of 2531 individuals from the Age-Related Eye Disease Study, among which 525 eyes progressed to GA and 4165 eyes did not. METHODS: Eyes without advanced AMD at baseline were evaluated for progression to GA. Behavioral data, including smoking and body mass index measurements, were collected at baseline using questionnaires. Dietary data were collected from food frequency questionnaires (FFQs) at baseline. Omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]), omega-6 fatty acids, monounsaturated, saturated, polyunsaturated, and total fat were adjusted for sex and calories and divided into quintiles (Q). Eight single nucleotide polymorphisms in 7 genes (CFH, ARMS2/HTRA1, CFB, C2, C3, CFI, and LIPC) were genotyped. Cox proportional hazards models were used to test for associations between incident GA and intake of dietary lipids and interaction effects between dietary fat intake and genetic variation on risk of GA. MAIN OUTCOME MEASURES: Associations between dietary fat intake reported from FFQs, genetic variants, and incident GA. RESULTS: Increased intake of DHA was significantly associated with reduced risk of progression to GA in models with behavioral factors (model A) plus genetic variants (model B) (P trend = 0.01 and 0.03, respectively). Total omega-3 long chain polyunsaturated (DHA + EPA) fatty acid intake was significantly associated with reduced risk of progression in model B (P trend = 0.02). Monounsaturated fat was associated with increased risk in model A (P trend = 0.05). DHA intake was significantly associated with reduced risk of incident GA among those with the ARMS2/HTRA1 homozygous risk genotype (hazard ratio [HR] Q5 vs Q1, 0.4; P = 0.002; P for interaction between gene and fat intake = 0.05). DHA was not associated with reduced risk of GA among those with the homozygous ARMS2/HTRA1 nonrisk genotype (HR, 1.0; P = 0.90). CONCLUSIONS: Increased self-reported dietary intake of omega-3 fatty acids is associated with reduced risk of GA and may modify genetic susceptibility for progression to GA. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Authors: E Cho; S Hung; W C Willett; D Spiegelman; E B Rimm; J M Seddon; G A Colditz; S E Hankinson Journal: Am J Clin Nutr Date: 2001-02 Impact factor: 7.045
Authors: Lucia Sobrin; Robyn Reynolds; Yi Yu; Jesen Fagerness; Nicolas Leveziel; Paul S Bernstein; Eric H Souied; Mark J Daly; Johanna M Seddon Journal: Am J Ophthalmol Date: 2010-12-03 Impact factor: 5.258
Authors: Lucia Sobrin; Stephan Ripke; Yi Yu; Jesen Fagerness; Tushar R Bhangale; Perciliz L Tan; Eric H Souied; Gabriëlle H S Buitendijk; Joanna E Merriam; Andrea J Richardson; Soumya Raychaudhuri; Robyn Reynolds; Kimberly A Chin; Aaron Y Lee; Nicolas Leveziel; Donald J Zack; Peter Campochiaro; R Theodore Smith; Gaetano R Barile; Ruth E Hogg; Usha Chakravarthy; Timothy W Behrens; André G Uitterlinden; Cornelia M van Duijn; Johannes R Vingerling; Milam A Brantley; Paul N Baird; Caroline C W Klaver; Rando Allikmets; Nicholas Katsanis; Robert R Graham; John P A Ioannidis; Mark J Daly; Johanna M Seddon Journal: Ophthalmology Date: 2012-06-15 Impact factor: 12.079
Authors: Ulrike Friedrich; Connie A Myers; Lars G Fritsche; Andrea Milenkovich; Armin Wolf; Joseph C Corbo; Bernhard H F Weber Journal: Hum Mol Genet Date: 2011-01-20 Impact factor: 6.150
Authors: Amy E Millen; Kristin J Meyers; Zhe Liu; Corinne D Engelman; Robert B Wallace; Erin S LeBlanc; Lesley F Tinker; Sudha K Iyengar; Jennifer G Robinson; Gloria E Sarto; Julie A Mares Journal: JAMA Ophthalmol Date: 2015-10 Impact factor: 7.389
Authors: Juan E Grunwald; Maxwell Pistilli; Ebenezer Daniel; Gui-Shuang Ying; Wei Pan; Glenn J Jaffe; Cynthia A Toth; Stephanie A Hagstrom; Maureen G Maguire; Daniel F Martin Journal: Ophthalmology Date: 2016-10-27 Impact factor: 12.079
Authors: M Cristina Kenney; Marilyn Chwa; Shari R Atilano; Payam Falatoonzadeh; Claudio Ramirez; Deepika Malik; Mohamed Tarek; Javier Cáceres-del-Carpio; Anthony B Nesburn; David S Boyer; Baruch D Kuppermann; Marquis Vawter; S Michal Jazwinski; Michael Miceli; Douglas C Wallace; Nitin Udar Journal: Hum Mol Genet Date: 2014-02-28 Impact factor: 6.150
Authors: Eiichi Hasegawa; Saori Inafuku; Lama Mulki; Yoko Okunuki; Ryoji Yanai; Kaylee E Smith; Clifford B Kim; Garrett Klokman; Diane R Bielenberg; Narender Puli; John R Falck; Deeba Husain; Joan W Miller; Matthew L Edin; Darryl C Zeldin; Kin Sing Stephen Lee; Bruce D Hammock; Wolf-Hagen Schunck; Kip M Connor Journal: Proc Natl Acad Sci U S A Date: 2017-08-21 Impact factor: 11.205
Authors: Freekje van Asten; Chi-Yang Chiu; Elvira Agrón; Traci E Clemons; Rinki Ratnapriya; Anand Swaroop; Michael L Klein; Ruzong Fan; Emily Y Chew Journal: Ophthalmology Date: 2019-06-12 Impact factor: 12.079
Authors: Kristin J Meyers; Zhe Liu; Amy E Millen; Sudha K Iyengar; Barbara A Blodi; Elizabeth Johnson; D Max Snodderly; Michael L Klein; Karen M Gehrs; Lesley Tinker; Gloria E Sarto; Jennifer Robinson; Robert B Wallace; Julie A Mares Journal: Ophthalmology Date: 2015-09-06 Impact factor: 12.079